Morocco medicine price database

KEPPRA

250 MG · film-coated tablet · box of 60

lévétiracétam

Reference dated : 2026-06-02. Confirm price and availability with a pharmacist.

Public price

294,00 MAD

Laboratory

GLAXO SMITHKLINE

What is this medicine?

French reference leaflet: LEVETIRACETAM VIATRIS 250 mg, comprimé pelliculé. Confirm indications in Morocco with a pharmacist.

Pharmacotherapeutic class: anti-epileptic, other anti-epileptics – ATC code: N03AX14. Levetiracetam is an anti-epileptic drug (a drug used to treat epileptic seizures). LEVETIRACETAM VIATRIS 250 mg, film-coated tablet is used: · alone, in adults and adolescents from 16 years of age presenting with a certain form of newly diagnosed epilepsy. Epilepsy is a disease in which patients have repeated seizures (convulsions). Levetiracetam is used for the form of epilepsy where seizures initially affect only one side of the brain, but which may subsequently spread to wider areas of both sides of the brain (partial seizure with or without secondary generalization). Levetiracetam has been prescribed to you by your doctor in order to reduce the number of seizures; · in association with other anti-epileptic drugs to treat: o partial seizures with or without generalization in adults, adolescents, children and infants from 1 month of age, o myoclonic seizures (brief, jerky movements of a muscle or group of muscles) in adults and adolescents from 12 years of age having juvenile myoclonic epilepsy, o primary generalized tonic-clonic seizures (severe seizures with loss of consciousness) in adults and adolescents from 12 years of age having idiopathic generalized epilepsy (this type of epilepsy which is supposed to have a genetic cause).

Full clinical reference

Additional sections are available in French. Read the original document; the information concerns the French reference product.

Read the French reference

Hospital price

195,50 MAD

ATC code

N03AX14

Type

Originator

References and update dates

Historical reference; confirm the price with a pharmacist.

Base de données publique des médicaments (France) · 2026-09-29 · Licence Ouverte

Read medical reference

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 294,00 MAD

Referenced presentations and strengths

Same ingredient, strength and form

This grouping does not establish interchangeability.

Other strengths and forms

Routes and instructions may differ.